MedPage Today August 27, 2024
Kristen Monaco

— SmartAdjust technology is used in Insulet’s Omnipod 5 Automated Insulin Delivery System

The FDA cleared the first automated insulin dosing device for adults with type 2 diabetes, the agency announced on Monday.

An interoperable automated glycemic controller, Insulet’s SmartAdjust technology is software that automatically adjusts insulin delivery by connecting to an alternate controller-enabled insulin pump and integrated continuous glucose monitor.

Used in Insulet’s tubeless Omnipod 5 Automated Insulin Delivery (AID) System, the technology eliminates the need for multiple daily injections by automatically adjusting insulin delivery every 5 minutes.

“The FDA has long worked with the diabetes community to ensure access to additional options and flexibilities for diabetes management,” said Michelle Tarver, MD, PhD, acting director of the FDA’s Center...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: FDA, Govt Agencies, Medical Devices
Related Articles:
Marty Makary, Who Made His Name Bashing the Medical Establishment, May Soon Lead FDA
Gutting FDA Won't Make America Healthy
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance
FDA Annual Flu Vaccine Meeting and CDC’s ‘Wild to Mild’ Campaign Canceled
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency

Share This Article